RAPPORT THERAPEUTICS INC (RAPP:NASDAQ)
$30.65 0.8 (2.6801%)
Analysed RAPPORT THERAPEUTICS INC (RAPP:NASDAQ) News Sources
Rapport Therapeutics Reports First Quarter 2026 Financials and Provides Business Update
07-05-2026
yahoo.com
Rapport Therapeutics to Participate in the Jefferies Global Healthcare Conference and Goldman Sachs 47th Annual Global Healthcare Conference
20-05-2026
yahoo.com
BTIG Raises its Price Target on Rapport Therapeutics (RAPP)
05-06-2026
yahoo.com
Is Rapport Therapeutics (RAPP) Using RAP-219 To Redefine Its Broader Neuroscience Investment Narrative?
08-06-2026
yahoo.com
What Does the Sale of Rapport Therapeutics Stock Worth Over $400,000 by the Chief Operating Officer Mean for Investors?
12-07-2026
fool.com
Rapport Therapeutics Reports Second Quarter 2026 Financials and Provides Business Update
05-08-2026
yahoo.com
Rapport Therapeutics to Host Virtual KOL Event on the Unmet Need in Bipolar Mania and the RAP-219 Clinical Program
24-08-2026
yahoo.com
Rapport Therapeutics to Participate in Upcoming Investor Conferences
02-09-2026
yahoo.com
The Zacks Analyst Blog Highlights Kodiak Sciences, Celldex Therapeutics, Rapport Therapeutics and Vaxcyte
23-09-2026
yahoo.com
The Biggest Losers In Biotech — And It Had Nothing To Do With 'Compelling,' 'Best-In-Disease' Data
23-09-2026
yahoo.com
What is the current price of RAPPORT THERAPEUTICS INC (RAPP:NASDAQ)?
The current price of RAPPORT THERAPEUTICS INC (RAPP:NASDAQ) is $30.65.
RAPPORT THERAPEUTICS INC (RAPP:NASDAQ) absolute price change since previous trading day?
The absolute price change of RAPPORT THERAPEUTICS INC (RAPP:NASDAQ) since the previous trading day is $0.8.
RAPPORT THERAPEUTICS INC (RAPP:NASDAQ) percentage price change since previous trading day?
The percentage price change of RAPPORT THERAPEUTICS INC (RAPP:NASDAQ) since the previous trading day is 2.6801%.
What is the most recent average sentiment score for RAPPORT THERAPEUTICS INC (RAPP:NASDAQ)?
The most recent average sentiment score for RAPPORT THERAPEUTICS INC (RAPP:NASDAQ) is 81 out of 100.
What is the most recent average sentiment for RAPPORT THERAPEUTICS INC (RAPP:NASDAQ)?
The most recent sentiment for RAPPORT THERAPEUTICS INC (RAPP:NASDAQ) is .
SEC-8K** Filing Available For RAPPORT THERAPEUTICS INC (RAPP:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.